02/23/2024 23:28:06
  • Home | Invest in Tech
  • In this issue
  • Gerteis Company Insight
  • Gerteis
  • Contents
  • DJA
  • News
  • Medelpharm
  • Biotech M&A: will the 2018 surge last?
  • NSF
  • Can the gene and cell therapy revolution scale up?
  • Haselmeier GmbH Company Insight
  • Haselmeier GmbH
  • Gut instinct: how common drugs affect the microbiome
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Tracing the story of mumps: a timeline
  • Molnar Company Insight
  • Molnar
  • Inside Swiss pharma: the ideal environment for success
  • Is the UK’s drug evaluation system in need of an overhaul?
  • Scandinavian Health Ltd. Company Insight
  • Scandinavian Health Ltd.
  • Moehs
  • Could digital tech unlock billions in savings for pharma companies?
  • Ecocool
  • CRISPR: a seismic shift in gene editing
  • Mestra AG (Endress + Hauser)
  • Events
  • Pfanstiehl Inc Company Insight
  • Pfanstiehl Inc.
  • Next issue
  • Niconex Medical Ltd
  • Alpex Pharma SA
  • Pall Biotech Company Insight
  • Pall Biotech
  • AtoZ-CRO GmbH
  • WIKA - Disaster prevention
  • Bea Technologies
  • Baxter
  • Suez
  • Raland Compliance Partners
05/24/2018 00:00:00